Growth arrest and DNA damage-inducible protein 45a (GADD45a) is an important cell cycle checkpoint protein that arrests cells at G2/M phase by inhibiting the activity of G2-speci®c kinase, cyclin B/p34cdc2. We report here that arsenite induces GADD45a expression in a p53-independent fashion and that this GADD45a induction by arsenite is regulated by NF-kB and c-Jun-N-terminal kinase (JNK) oppositely. In human bronchial epithelial cells overexpressing a kinase-mutated form of IkB kinase b (IKKb-KM), the activation of NF-kB was inhibited. However, the G2/M cell cycle arrest and expression of GADD45a was substantially enhanced in response to arsenite in these cells. Expression of a dominant-negative mutant of SEK1 that blocks JNK activation decreased arsenite-induced GADD45a expression. Analysis of GADD45a expression in both wild-type and p537/7 ®broblasts indicated that the induction of GADD45a by arsenite was independent of the status of p53 protein. Oncogene (2001) 20, 3585 ± 3589. 
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Emerging evidence indicates that arsenite acts as a potent environmental and occupational carcinogen by inducing cell cycle disregulation, cytogenetic alterations, anchorage independence, aneuploidy, and gene ampli®cation, characteristics that are commonly observed in most tumor cells (Gebel, 2000; Guha Mazumder et al., 1998; Huang and Lee, 1998; Kayajanian, 2000; Styblo et al., 1999) . The exact molecular mechanisms that account for the carcinogenic eect of arsenite remain to be investigated. It has been hypothesized that some of the eects of arsenite are due to aberrant regulation of mitogen-activated protein (MAP) kinases and several transcription factors, such as AP-1 and nuclear factor kB (NF-kB) (Cavigelli et al., 1996; Hamilton et al., 1998) . These transcription factors are important in the regulation of a number of early response genes involved in cell migration, cell cycle progression, apoptosis, and carcinogenesis.
In mammalian cells, cell cycle transition is under the control of a tightly regulated network of cell division kinases (cdks) and a number of surveillance mechanisms, the so-called checkpoints (Russell, 1998) . GADD45 family is one of several known checkpoint proteins that arrests cells at G2/M phase by inhibiting the activity of cyclin B/p34cdc2 complex in response to stress (Jin et al., 2000a; Wang et al., 1999b; Yang et al., 2000) . Currently, three GADD45 isoforms have been identi®ed. The dierent isoforms, named GADD45a, GADD45b and GADD45g, show similar structural characteristics and expression patterns in response to extracellular stimuli (Takekawa and Saito, 1998) . GADD45a was originally identi®ed as a gene whose expression is rapidly induced in response to unreplicated DNA or DNA damage in a p53-dependent manner (Kastan et al., 1992) . However, there are several reports suggesting that some stress inducers induce GADD45a in the absence of active p53 (Jin et al., 2000b; O'Reilly et al., 2000) . Both NF-kB and cJun-N-terminal kinase (JNK) are well-established stress sensors and have been indicated as important mediators regulating stress-induced cell apoptosis (Karin and Delhase, 1998) . However, little is known regarding their roles in the regulation of cell cycle in response to stressers.
To determine the roles of NF-kB in arsenite-induced cellular responses, we established several stably transfected human bronchial epithelial cell lines (BEAS-2B) in which the activation pathway for the NF-kB has been speci®cally inhibited by over-expression of a kinase-mutated form of IKKb (IKK-KM) along with a NF-kB-dependent luciferase reporter construct. As a control, some cells were transfected with a vector expressing a wild-type IKKb, the major IkBa kinase activated in response to a variety of in¯ammatory stimuli. In agreement with previous reports (Chu et al., 1999; Geleziunas et al., 1998) , stable expression of wild-type IKKb did not alter basal or inducible IKK or NF-kB activation compared to the transfection of an empty vector (data not shown). Analysis of NF-kB-dependent luciferase activity indicates that arsenite treatment of IKKb-expressing cells induces a dose-dependent increase of luciferase reporter gene activity (Figure 1a ). Peak activation of NF-kB-dependent reporter gene by arsenite occurred between 15 to 20 mM. In contrast, no induction of NF-kBdependent luciferase activity was observed in the cells expressing IKKb-KM in response to arsenite at any given concentrations. These results indicate that the IKKb, a pivotal signaling component for NF-kB activation is defective in the cells expressing IKKb-KM.
IKKb gene knockout studies suggested that the activation pathways for the MAP kinases are normal in mice with IKKb gene interruption . Consistent with this notion, no impairment of Erk, JNK and p38 was observed in the cells stably expressing IKKb-KM ( Figure 1b and data not shown). In fact, we noticed a greater enhancement of JNK activation in IKKb-KM cells than that in IKKb cells (Figure 1b) .
NF-kB has been considered as an important antiapoptotic transcription factor under many circumstances . To determine whether NF-kB inhibition by expression of IKKb-KM aects arsenite-induced cell growth, cell apoptosis and cell cycle pro®le were measured by¯ow cytometry. Both unsynchronized IKKb-expressing cells and unsynchronized IKKb-KM cells were stimulated with 10 mM arsenite for 48 h and then subjected to¯ow cytometry analysis. Under the basal condition, both IKKb cells and IKKb-KM cells had similar cell cycle distributions (Figure 2a) . Arsenite treatment of IKKb-KM cells caused a signi®cant accumulation of the cells in G2/M phase with a concomitant disappearence of the G1 fraction. In contrast, in IKKb cells, arsenite only induced a marginal change of G1 and G/M fractions. No sub-G1 fraction was detected in this assay in either type of cell stimulated with arsenite, indicating apoptosis did not occur.
The above results indicate that NF-kB inhibition by expression of IKKb-KM potentiated G2/M phase cell cycle arrest. To further dissect the eects of NF-kB on the cell cycle alteration induced by arsenite, we analysed the expression of GADD45a, a recently identi®ed inhibitor for cyclin B/p34cdc2 complex required for the G2/M phase transition (Jin et al., 2000a; Wang et al., 1999b; Yang et al., 2000) . Figure 2b shows that after arsenite treatment, IKKb-KM cells express more GADD45a protein than did IKKb cells. The induction of GADD45a in both types of Total cellular proteins were subjected to immunoblotting for the detection of GADD45a protein using 16% SDS ± PAGE gels cells occurs in a dose-dependent manner. Arsenite at both lower concentrations (1.25 and 2.5 mM) and higher concentrations (5 and 10 mM) induced a noticeable expression of GADD45a protein in IKKb-KM cells (Figure 2b , lanes 7 ± 10). In IKKb cells, in contrast, only higher concentrations of arsenite induced appreciable expression of GADD45a (lanes 4 and 5).
Since we observed that NF-kB inhibition by expression of IKKb-KM enhanced arsenite-induced JNK activation, we reasoned that the enhanced JNK activation in IKKb-KM cells might be responsible for the elevated induction of GADD45a by arsenite. To determine whether JNK contributes to arsenite-induced GADD45a expression, IKKb-KM cells were transiently transfected with a vector expressing a dominantnegative mutant of SEK1, an upstream kinase activating JNK. Compared to control vector (pcDNA) transfection (Figure 3, lanes 1 ± 5) , immunoblotting experiments showed a reduced activation of JNK in these IKKb-KM cells transfected with mutated SEK1 (SEK1-KM) following arsenite treatment (Figure 3 , top panel, lanes 6 ± 10). The expression of SEK1-KM caused an appreciable suppression of GADD45a induction by arsenite (Figure 3 , bottom panel, lanes 6 ± 10).
GADD45a has been initially considered as a p53-target gene whose transcription/expression is under the control of the p53 activation (Hollander et al., 1993; Yu et al., 1999) . The cells used in this study, however, were previously shown to express a functionally de®cient p53 protein (Gerwin et al., 1992; Lehman et al., 1993) . Furthermore, no change of the N-terminal serine 15 phosphorylation of p53 protein was noted in either IKKb or IKKb-KM cells in response to arsenite (Figure 4a ). To address whether p53 is involved in arsenite-induced GADD45a expression, we next determined the induction of GADD45a by arsenite in mouse embryo ®broblast (MEF) cells derived from wild-type mice (p53+/+) and p53 gene knockout mice (p537/7), respectively. Figure 4b showed that arsenite was able to induce the increase of serine 15 phosphorylation in p53+/+ cells (lanes 1 ± 5) but not in p537/7 cells (lanes 6 ± 10). Assessment of protein expression revealed no de®ciency in GADD45a induction by arsenite in p537/7cells. In fact, GADD45a induction by arsenite was actually higher in the p537/ 7 cells relative to p53+/+ cells (Figure 4b , bottom panel, compare lanes 9 and 10 with lanes 4 and 5. These results suggest that the induction of GADD45a by arsenite is p53-independent.
In this study we provide evidence that NF-kB and JNK oppositely regulate arsenite-induced expression of GADD45a, a cell cycle checkpoint protein inhibiting the activity of cyclin B/p34cdc2 complex and arresting cell cycle at G2/M phase (Jin et al., 2000a; Wang et al., 1999b; Yang et al., 2000) . Inhibition of NF-kB by expression of a kinase-mutated IKKb, IKKb-KM, potentiated the G2/M phase cell cycle arrest and GADD45a expression in response to arsenite. Interruption of JNK signaling pathway by transfecting the cells with a kinase-mutated SEK1, on the other hand, decreased the induction of GADD45a by arsenite. In addition, using ®broblasts originated from wild-type and p53 gene knockout mice, we here demonstrated that arsenite-induced GADD45a is independent of the status of p53. 5) or a vector expressing a kinase-mutated form of SEK1 to inhibit JNK activation pathway speci®cally (lanes 6 ± 10). Cells were further treated with various doses of arsenite for an additional 12 h. Total cellular proteins were prepared and subjected to immunoblotting for the determination of phosphorylation of JNK1/2 (top panel), non-phosphorylated JNK1/2 (middle panel) and GADD45a expression (bottom panel) Figure 4 Arsenite-induced GADD45a expression was p53-independent. (a) BEAS-2B cells stably expressing IKKb (lanes 1 ± 5) or IKKb-KM (lanes 6 ± 10) were treated with various doses of arsenite for 12 h. Total proteins were prepared and subjected to immunoblotting using antibody against serine 15-phosphorylated p53 protein. (b) Mouse embryonic ®broblasts derived from both wild-type mice (p53+/+) (lanes 1 ± 5) and p53 gene knockout mice (p537/7) (lanes 6 ± 10) were treated with various doses of arsenite for 12 h, respectively. Total cellular proteins were prepared and subjected to immunoblotting using antibodies against serine 15-phosphorylated p53 protein (upper panel) or GADD45a protein (lower panel) Mechanistic studies indicated a possible non-IKK signaling pathway mediating arsenite-induced NF-kB activation in several types of cells (Jaspers et al., 1999; Kapahi et al., 2000) . Interruption of IKK activity by overexpression of IKKb-KM, however, may either block the basal NF-kB activity or the auto-amplifying loop of NF-kB that requires IKKb. The ability of arsenite on the activation of NF-kB appears to be dose-and cell type-dependent (Barchowsky et al., 1996; Hamilton et al., 1998) . In the present study, we demonstrated that arsenite induced NF-kB-dependent reporter gene activity in a narrow dose-range (4 ± 30 mM). Consistent with previous reports that higher concentrations of arsenite might interfere with the DNA binding of NF-kB (Roussel and Barchowsky, 2000) , we observed an inhibitory eect of arsenite at concentrations of more than 30 mM on NF-kB reporter gene activity.
NF-kB has been considered as a positive transcriptional regulator for most NF-kB target genes. However, several recent reports have demonstrated that NF-kB might also serve as a negative regulator on its target genes (Du et al., 2000; Guttridge et al., 2000) , such as MyoD and proteasome C3. Examination of the nucleotide sequence of human GADD45a promoter and introns showed several sequences homologous to consensus NF-kB-binding sites at the regions of promoter, intron 1 and intron 3. The intron 3 NFkB-binding site (4529-GTAATTACCC-4538, GenBank L24498) is located at nucleotide position next to the BRCA1/ZBRK1 binding site (4497-GGGTTCA-GACTTT-4509), a site that is required for the p53-independent induction of GADD45a by BRCA1 (Harkin et al., 1999; Zheng et al., 2000) . We are currently investigating if the binding of NF-kB on this site interferes with the transcriptional regulation of BRCA1/ZBRK1 on GADD45a.
The relationship between JNK and GADD45a is controversial. Studies by Takekawa and Saito (1998) indicated that GADD45a interacted and activated MEKK4, a MAPK kinase kinase activating JNK and p38. This observation, however, was contradicting by the two follow-up studies using gadd45a-gene knockout embryonic ®broblasts or cells in which the GADD45a expression was diminished (Shaulian and Karin, 1999; Wang et al., 1999a) . Using a dominantnegative SEK1 to block JNK activation induced by arsenite, we observed a reduced expression of GADD45a, indicating that JNK activation is an upstream, rather than a down-stream event in GADD45a induction by arsenite.
Arsenite is a non-genotoxic carcinogen ubiquitously existed in a number of environmental and occupational settings . A better understanding of arsenite eects on MAP kinase activation, NF-kB activity and cell cycle regulation may provide better insights into elucidating the oncogenic properties of arsenite and establishing novel preventive and therapeutic strategies of arseniteinduced human diseases.
